OCRX

Ocera Therapeutics, Inc.
OCRX

Overview Fund Activity
Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

29 hedge funds and large institutions have $22.4M invested in Ocera Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 2 closing their positions.

Holders
29
Holders Change
+2
Holders Change %
+7.41%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
6
Closed
2
Calls
$50K
Puts
–
Net Calls
+$50K
Net Calls Change
+$50K

Top Buyers

1
QF
1
QVT Financial
New York
$2.91M
2
TI
2
Turner Investments
Pennsylvania
$2.1M
3
SFM
3
Sphera Funds Management
Israel
$1.72M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$328K
5
Citadel Advisors
5
Citadel Advisors
Florida
$59K

Top Sellers

1
SM
1
Sabby Management
Florida
$1.2M
2
ECM
2
Endurant Capital Management
California
$428K
3
NI
3
Numeric Investors
Massachusetts
$0
4
Millennium Management
4
Millennium Management
New York
$1.67M
5
Deutsche Bank
5
Deutsche Bank
Germany
$1K
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$9K +$9K +2,942 New
BIM
27
BlackRock Investment Management
Delaware
$7K +$775 +264 +12%
Deutsche Bank
28
Deutsche Bank
Germany
$1K -$22.9K -10,261 -96%
Manulife (Manufacturers Life Insurance)
29
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5 – – –
NI
30
Numeric Investors
Massachusetts
– -$59K -18,600 Closed
Wells Fargo
31
Wells Fargo
California
– -$4K -1,325 Closed
1
2